Affiliation:
1. MBBS student, Government Medical College Thrissur.
2. MD General Medicine, Associate Professor, Department of Medicine, Government Medical College Thrissur.
3. MD Social and Preventive Medicine , Associate Professor, Department of Social and Preventive Medicine, Government Medical College Thrissur.
4. MD Genaral Medicine, Associate Professor, Department of Medicine, Jubilee Mission Medical College Thrissur.
Abstract
Background and Objectives: Sepsis is a common cause of mortality and morbidity especially in resource poor settings in India.[1] It is the need of
the hour to devise efcient and cheaper biomarkers to diagnose and predict prognosis in sepsis, so that appropriate antibiotic therapy can be
initiated. We conducted the study to nd out the predictability of 14 day mortality in patients with sepsis by combined biomarkers and also to
compare the diagnostic validity of the combined biomarkers with individual biomarkers. We enrolled eighty six patients (forty Methodology:
three consecutive cases with sepsis and an equal number of age and sex matched controls without sepsis).Convenient sampling was done. Study
period was for two months. All patients were followed up for a period of 14 days to assess mortality. Clinical and biochemical parameters were
analysed. Fourteen day mortality rate observed was 41.9% (18/43). Area under curve obtained Results: in ROC curves suggested combined
bioscore as a signicant predictor of mortality (0.724 ± 0.081). Combined bioscore of ≥ 3 had sensitivity of 77.8 % and specicity of 56 % in
predicting mortality. Combination of white cell count, absolute eosinophil count and platelet count was found to be the best predictor [sensitivity of
38.8 %, specicity of 96 %, PPV of 87.5 %, NPV of 68.6 % , ( p = 0.006) ]. In multivariate logistic regression, combined bioscore was found to be an
independent predictor of sepsis with a very signicant Odds Ratio of 10.661 ( 95 % CI, 2.179 – 52.165 ). The biomarkers which we Conclusion:
had analysed in combination could serve as a valuable predictor of 14 day mortality in sepsis. By selecting the right antibiotic based on severity of
sepsis, development of antimicrobial resistance and thus health care cost can be reduced.
Subject
Mechanical Engineering,Mechanics of Materials,Biomedical Engineering,Medicine (miscellaneous),Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine,General Immunology and Microbiology,Endocrine and Autonomic Systems,Endocrinology, Diabetes and Metabolism,Pharmacology (medical),Psychiatry and Mental health,Pharmacology,General Nursing,Food Science,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference17 articles.
1. Nelson GE, Mave V, Gupta A. Biomarkers for Sepsis : A review with special attention to India. Biomed Res Int 2014: 264351.
2. Dolin HH, Papadimos TJ, Stepkowski S, Chen X, Pan ZK. A novel combination of biomarkers to herald the onset of sepsis prior to the manifestation of symptoms. Shock 2018; 49 (4) : 364-370.
3. Savitri K, Kate A, Gavin B. Diagnostic and prognostic biomarkers of sepsis in critical care. Journal of Antimicrobial chemotherapy 2011; 66: 33-40.
4. Candel FJ, Borges Sá M, Belda S, Bou G, Pozo J, Estrada O et al. Current aspects in sepsis approach. Turning things around. Rev Esp Quimioter. 2018 ; 31 (4) : 298 – 315.
5. Ho KM, Towler SC. A comparison of eosinopenia and C- reactive protein as a marker of blood stream infections in critically ill patients : a case- control study. Anaesth Intensive Care 2009 ;37:450-6.